SCHEDULE: Bank of America Discloses Minimal ENvue Medical Stake

Bank of America Corporation has filed an amendment to Schedule 13G, disclosing beneficial ownership of 14 shares, representing 0.0% of ENvue Medical, Inc.'s common stock.

Summary

• Bank of America Corporation filed an Amendment No. 1 to Schedule 13G regarding its beneficial ownership in ENvue Medical, Inc.
• The filing indicates Bank of America beneficially owns 14 shares of ENvue Medical's Common Stock.
• This represents 0.0% of the class, based on 1,088,192 outstanding shares as of December 5, 2025.
• The shares are held with shared voting power and shared dispositive power.
• The acquisition and holding of these securities are stated to be in the ordinary course of business, not for influencing control of the issuer.
• The filing is made by Bank of America Corporation on behalf of its wholly-owned subsidiaries BofA Securities, Inc. (a broker-dealer) and Bank of America N.A. (a bank).

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it is a standard regulatory disclosure of a negligible beneficial ownership stake, providing no material positive or negative information about ENvue Medical, Inc.

Future Outlook

No forward-looking statements or guidance are provided in this disclosure filing.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are routine disclosures by institutional investors who acquire beneficial ownership of more than 5% of a company's voting class of securities, or in this case, an amendment to a previous filing. This specific filing indicates a de minimis holding by Bank of America, suggesting no significant investment or strategic interest in ENvue Medical, Inc. from this entity.

Comparison to Industry Standards

• This filing is a standard regulatory disclosure.
• The reported 0.0% ownership by Bank of America is negligible and does not indicate any significant institutional investment activity comparable to major stakes held by mutual funds or hedge funds in other public companies.
• For instance, large institutional investors often hold several percentage points or more in companies like Apple (AAPL) or Microsoft (MSFT), whereas this filing shows a virtually non-existent position.

Stakeholder Impact

• This filing has minimal direct impact on shareholders, employees, customers, suppliers, or creditors due to the extremely small ownership percentage disclosed.
• It primarily serves as a regulatory update on institutional holdings.

Key Dates

Keywords

ENvue Medical, Bank of America, Schedule 13G, Beneficial Ownership, Common Stock, SEC Filing, Institutional Ownership